CZMWY
Price
$61.41
Change
+$1.01 (+1.67%)
Updated
Jan 30 closing price
Capitalization
10.39B
12 days until earnings call
SONVY
Price
$70.13
Change
+$0.37 (+0.53%)
Updated
Jan 30 closing price
Capitalization
16.61B
Ad is loading...

CZMWY vs SONVY

Header iconCZMWY vs SONVY Comparison
Open Charts CZMWY vs SONVYBanner chart's image
Carl Zeiss Meditec AG
Price$61.41
Change+$1.01 (+1.67%)
Volume$2.65K
Capitalization10.39B
Sonova Holding AG
Price$70.13
Change+$0.37 (+0.53%)
Volume$15.32K
Capitalization16.61B
CZMWY vs SONVY Comparison Chart
Loading...
CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CZMWY vs. SONVY commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CZMWY is a Buy and SONVY is a Buy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (CZMWY: $61.41 vs. SONVY: $70.13)
Brand notoriety: CZMWY and SONVY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CZMWY: 20% vs. SONVY: 46%
Market capitalization -- CZMWY: $10.39B vs. SONVY: $16.61B
CZMWY [@Medical Specialties] is valued at $10.39B. SONVY’s [@Medical Specialties] market capitalization is $16.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CZMWY’s FA Score shows that 1 FA rating(s) are green whileSONVY’s FA Score has 2 green FA rating(s).

  • CZMWY’s FA Score: 1 green, 4 red.
  • SONVY’s FA Score: 2 green, 3 red.
According to our system of comparison, SONVY is a better buy in the long-term than CZMWY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CZMWY’s TA Score shows that 4 TA indicator(s) are bullish while SONVY’s TA Score has 4 bullish TA indicator(s).

  • CZMWY’s TA Score: 4 bullish, 5 bearish.
  • SONVY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SONVY is a better buy in the short-term than CZMWY.

Price Growth

CZMWY (@Medical Specialties) experienced а +10.31% price change this week, while SONVY (@Medical Specialties) price change was +0.95% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.36%. For the same industry, the average monthly price growth was +5.90%, and the average quarterly price growth was +7.18%.

Reported Earning Dates

CZMWY is expected to report earnings on May 12, 2025.

SONVY is expected to report earnings on Nov 19, 2024.

Industries' Descriptions

@Medical Specialties (+1.36% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SONVY($16.6B) has a higher market cap than CZMWY($10.4B). CZMWY has higher P/E ratio than SONVY: CZMWY (33.11) vs SONVY (22.22). CZMWY YTD gains are higher at: 29.284 vs. SONVY (7.826). SONVY has higher annual earnings (EBITDA): 979M vs. CZMWY (481M). SONVY has higher revenues than CZMWY: SONVY (3.74B) vs CZMWY (2.02B).
CZMWYSONVYCZMWY / SONVY
Capitalization10.4B16.6B63%
EBITDA481M979M49%
Gain YTD29.2847.826374%
P/E Ratio33.1122.22149%
Revenue2.02B3.74B54%
Total Cash44.3MN/A-
Total Debt211MN/A-
FUNDAMENTALS RATINGS
CZMWY vs SONVY: Fundamental Ratings
CZMWY
SONVY
OUTLOOK RATING
1..100
267
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
10046
SMR RATING
1..100
7550
PRICE GROWTH RATING
1..100
5148
P/E GROWTH RATING
1..100
8024
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CZMWY's Valuation (8) in the null industry is in the same range as SONVY (13). This means that CZMWY’s stock grew similarly to SONVY’s over the last 12 months.

SONVY's Profit vs Risk Rating (46) in the null industry is somewhat better than the same rating for CZMWY (100). This means that SONVY’s stock grew somewhat faster than CZMWY’s over the last 12 months.

SONVY's SMR Rating (50) in the null industry is in the same range as CZMWY (75). This means that SONVY’s stock grew similarly to CZMWY’s over the last 12 months.

SONVY's Price Growth Rating (48) in the null industry is in the same range as CZMWY (51). This means that SONVY’s stock grew similarly to CZMWY’s over the last 12 months.

SONVY's P/E Growth Rating (24) in the null industry is somewhat better than the same rating for CZMWY (80). This means that SONVY’s stock grew somewhat faster than CZMWY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CZMWYSONVY
RSI
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
43%
Momentum
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
Bullish Trend 3 days ago
57%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 5 days ago
55%
Bullish Trend 5 days ago
66%
Declines
ODDS (%)
Bearish Trend 29 days ago
77%
Bearish Trend 3 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
51%
Aroon
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
51%
View a ticker or compare two or three
Ad is loading...
CZMWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SUICX49.88N/A
N/A
DWS CROCI International C
GGCCX91.50N/A
N/A
Gabelli Growth C
BWNYX27.50N/A
N/A
Bullfinch Greater Western New York
VYRDX17.39N/A
N/A
VY® Columbia Small Cap Value II R6
FIQAX15.81N/A
N/A
Fidelity Advisor Asset Manager 60% Z

CZMWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CZMWY has been loosely correlated with SMMNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CZMWY jumps, then SMMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWY
1D Price
Change %
CZMWY100%
+1.67%
SMMNY - CZMWY
44%
Loosely correlated
+0.78%
SONVY - CZMWY
38%
Loosely correlated
+0.53%
SAUHY - CZMWY
37%
Loosely correlated
+1.45%
ALGN - CZMWY
37%
Loosely correlated
+0.41%
ALC - CZMWY
36%
Loosely correlated
+1.03%
More

SONVY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONVY has been loosely correlated with ALC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SONVY jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONVY
1D Price
Change %
SONVY100%
+0.53%
ALC - SONVY
51%
Loosely correlated
+1.03%
SAUHY - SONVY
48%
Loosely correlated
+1.45%
AORT - SONVY
42%
Loosely correlated
+0.48%
SNN - SONVY
40%
Loosely correlated
+1.38%
OFIX - SONVY
39%
Loosely correlated
-0.32%
More